| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $24.7M | +0.5% |
| Cost of Revenue | $18.2M | +1.0% |
| Gross Profit | $6.5M | -0.9% |
| R&D Expense | $167K | +6.8% |
| SG&A Expense | $3.5M | +10.4% |
| Operating Income | -$69K | -139.7% |
| Pre-tax Income | -$448K | -89.0% |
| Income Tax | $0 | -100.0% |
| Net Income | -$448K |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5K | — |
| Accounts Receivable | $1.6M | +50.8% |
| Inventory | $3.6M | +9.1% |
| Current Assets | $6.0M | +9.3% |
| Total Assets | $8.8M | -4.1% |
| Current Liabilities | $5.0M | +19.8% |
| Long-term Debt | $704K | -17.6% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$410K | -186.3% |
| Capital Expenditures | $41K | -42.3% |
| Investing Cash Flow | -$41K | +42.3% |
| Financing Cash Flow | $158K | +137.9% |
| Free Cash Flow | -$451K | -211.6% |
| -12.3% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Total Liabilities |
| $6.3M |
| +0.7% |
| Stockholders' Equity | $2.4M | -14.5% |